Your session is about to expire
← Back to Search
Optical and infrared imaging for Breast Cancer
N/A
Waitlist Available
Led By Michele Svatos, PhD
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
- All female patients referred for adjuvant radiotherapy following breast conserving surgery/mastectomy.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week five of radiation treatment
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to develop software that uses photos and heat images of patients' skin to predict early skin problems during radiotherapy. It targets radiotherapy patients who often suffer from painful redness. The software works by analyzing these images to spot early signs of skin issues, allowing for timely interventions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week eight, follow-up after treatment.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week eight, follow-up after treatment.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Establish the correlation between optical and IR skin imaging and skin toxicity
Secondary study objectives
Skin
Diagnostic Imaging
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Receiving optical and infrared imagingExperimental Treatment1 Intervention
This is the only arm of the study. All patients will have optical and infrared images acquired of skin on the treated and contralateral sides.
Find a Location
Who is running the clinical trial?
Nova Scotia Health AuthorityLead Sponsor
287 Previous Clinical Trials
94,315 Total Patients Enrolled
3 Trials studying Breast Cancer
136 Patients Enrolled for Breast Cancer
Michele Svatos, PhDPrincipal InvestigatorDalhousie University
Share this study with friends
Copy Link
Messenger